Investing
Cathie Wood's ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier
Published:
Last Updated:
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 150,000 shares of Pfizer Inc. (NYSE: PFE) on Wednesday, as the price of this fund was flat in Wednesday’s session. It is still up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 158,788 shares of Pfizer. At Wednesday’s closing price, this would have valued this purchase at roughly $7.8 million. This is only a small fraction of the total holdings. The fund is up 31% over the past 52 weeks.
Check out all the ARK Invest buys for Wednesday:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | PATH | UiPath | 80,400 |
ARKF | PLTR | Palantir Technologies | 93,189 |
ARKF | Z | Zillow | 21,507 |
ARKG | RPTX | Repare Therapeutics | 3,791 |
ARKG | SURF | Surface Oncology | 41,741 |
ARKG | QSI | Quantum-Si | 130,116 |
ARKG | VCYT | Veracyte | 33,477 |
ARKG | PFE | Pfizer | 158,788 |
ARKG | NVTA | Invitae | 242,234 |
ARKG | ZY | Zymergen | 34,547 |
ARKG | MASS | 908 Devices | 21,511 |
ARKG | EXAS | Exact Sciences | 134,729 |
ARKG | DYNS | Dynamics Special Purpose | 92,700 |
ARKG | CRSP | CRISPR Therapeutics | 19,000 |
ARKG | SMFR | Sema4 | 307,823 |
ARKK | TSP | TuSimple | 130,152 |
ARKK | SRNG | Soaring Eagle Acquisition | 180,000 |
ARKK | SGFY | Signify Health | 120,721 |
ARKK | NVTA | Invitae | 118,534 |
ARKK | NTLA | Intellia Therapeutics | 67,593 |
ARKK | CRSP | CRISPR Therapeutics | 18,436 |
ARKK | BEAM | Beam Therapeutics | 4,174 |
ARKK | FATE | Fate Therapeutics | 102 |
ARKK | EDIT | Editas Medicine | 17,973 |
ARKQ | AVAV | Aerovironment | 19,814 |
ARKQ | BLDE | Blade Air Mobility | 14,731 |
ARKQ | KMTUY | Komatsu | 103,400 |
ARKQ | MKFG | Markforged | 102,260 |
ARKQ | TSP | TuSimple | 90,773 |
ARKW | CND | Concord Acquisition | 20,000 |
ARKW | GENI | Genius Sports | 241,657 |
ARKW | KVSB | Khosla Venture Acquisition II | 9,053 |
ARKW | LPSN | LivePerson | 46,116 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.